Langenfeld, Germany –, Oct. 15, 2026 (GLOBE NEWSWIRE) — Booking Health, a medical travel coordination service, announces medical records review, specialist second opinions and full treatment coordination for pancreatic cancer patients seeking care at certified German hospitals. The service helps families collect and translate medical documents, send cases to suitable German specialists, and receive proposed treatment programmes and cost estimates before committing. Booking Health also coordinates clinic appointments, airport and clinic transfers, interpreter support, and follow-up documentation so patients can focus on medical decisions. The announcement is illustrated through the experience of Helen and Lawrence Gray, who travelled from the UK to Germany after standard treatment options for stage 4 pancreatic cancer had been exhausted at home.
Helen Gray had already been through chemotherapy and radiotherapy when she and her husband Lawrence started looking into stage 4 pancreatic cancer treatment in Germany. Her diagnosis was pancreatic cancer that had spread to the liver. The couple wanted to explore additional options. So the couple flew to Munich. They didn’t go believing in a cure. They went to buy time and to find someone who could tell them what else existed.
This is their story, told largely in Lawrence’s own words. Not all of it is flattering. That’s partly why it’s worth reading.
A Diagnosis That Comes With a Clock
Stage 4 pancreatic cancer means the disease has spread beyond the pancreas. Roughly half of all patients are already at this stage when they’re diagnosed—because the pancreas sits deep in the abdomen and early symptoms are vague: back pain, indigestion, weight loss nobody can explain.
The numbers are hard. Cancer Research UK’s survival data put pancreatic cancer among the deadliest common cancers, and once it has metastasised, survival is lowest of all. Even the strongest standard chemotherapy combination, FOLFIRINOX, extended median survival to about 11 months in the landmark trial published in the New England Journal of Medicine. Eleven months, and that was the good result.
So families facing metastatic pancreatic cancer feel time differently. A six-week wait for a scan isn’t an inconvenience. It can be the difference between being eligible for a treatment and not.
Helen went through chemotherapy and radiotherapy. Then the couple found themselves in the place many families with metastatic pancreatic cancer reach eventually. The standard treatments had been used. Nobody was proposing anything else.
Why Germany
The answer was practical, not ideological.
Germany has a large network of certified cancer centres, a long tradition of pancreatic surgery at university hospitals, and a regulatory framework that lets individual patients access certain treatments outside trials. Some international patients can be seen within days or weeks. International patients can often be seen within days or weeks rather than months.
For the Grays, two things mattered:
- Speed. Something could happen now, rather than after another referral cycle.
- Access. A therapy the couple wanted to explore was available in Germany.
That therapy was dendritic cell immunotherapy. Their reasoning was specific, and it’s worth quoting in full: “We opted for this form of Immunotherapy in the hope of slowing its progress down so we could try get a second opinion organised at a centre of expertise.”
That sentence is the whole strategy. The immunotherapy was a bridge. The real goal was a pancreatic cancer second opinion on personalized pancreatic cancer treatment from people who specialise in exactly this disease.
What Dendritic Cell Therapy Is, and What It Isn’t
Dendritic cells are the immune system’s messengers. They pick up fragments of a threat and show them to T-cells, which then go looking for anything that carries the same markers.
In dendritic cell immunotherapy, the process works roughly like this:
- Blood is drawn and immune cells called monocytes are separated out.
- In a laboratory, these are grown into dendritic cells and exposed to tumour-associated antigens.
- The prepared cells are injected back into the patient, usually over several sessions.
The idea is sound. The evidence in pancreatic cancer is thin. Most dendritic cell vaccines remain investigational, and the US National Cancer Institute’s overview of cancer treatment vaccines is clear that very few have been approved for routine use. Pancreatic tumours are particularly good at suppressing immune responses, which is one reason immunotherapy has had less success here than in melanoma or some lung cancers.
Lawrence knew this going in. “Whether it has any effect at all is debatable,” he wrote, “but we decided to spend the money on it as nothing else was being offered in the UK.”
That’s an unusually clear-eyed statement from a patient’s family. It’s also the right frame for anyone considering personalized pancreatic cancer treatment abroad. A therapy can be legitimate, properly delivered and medically supervised, and still offer an uncertain benefit. Those things aren’t contradictory.
Ten Days in the Snow
The treatment itself took place at a clinic near Munich, in winter.
Booking Health arranged the trip: the clinic, the appointments, drivers to and from every visit. “This made the whole process easy and straightforward,” Lawrence said. When you’re travelling with a seriously ill person, straightforward is high praise.
Then there was Claudia, the translator. Most of the people the Grays dealt with spoke German, and Claudia’s job was to make sure they understood everything. She also translated, Lawrence admits, “when we probably had far too much to say.” Anyone who’s sat through a complicated medical conversation in a second language will recognise how much that matters. It’s not only about vocabulary. It’s about having someone in the room on your side.
The treatment “went forward efficiently as one might expect in Germany.” But not everything went smoothly. The amount of blood drawn for the cell preparation hit Helen harder than either of them had expected, and nobody had warned them. “My wife felt very tired the next day and struggled with her energy all the week when we tried to do a bit of tourism around Munich.”
That’s a fair criticism. A patient who’s already been through chemotherapy may be anaemic or depleted. Losing a significant volume of blood can leave them exhausted for days. It should be explained before treatment starts.
Still, the trip wasn’t only hospital corridors. The snow around Munich made for, in Lawrence’s words, spectacular scenery. And they went to a local comedy club. Lawrence credits the evening with keeping morale up. With a disease like this, that counts for something.
Choosing Treatment Wisely
Lawrence’s review ends with practical advice for other families: “make sure that you have good medical reasons for treatment.”
It’s sensible guidance. When standard options run out, families start searching widely, and the amount of information about advanced pancreatic cancer treatment can be overwhelming. Some offers are well founded. Others promise more than medicine can deliver. A good decision usually comes down to asking the right questions early.
A few that help:
- Is the clinic licensed to deliver the therapy it’s selling?
- Will the treating doctors review the full medical history, scans and pathology before agreeing to treat?
- Are realistic outcomes described?
- Are side effects and risks explained upfront?
- Does anyone talk about how this fits with standard metastatic pancreatic cancer treatment, rather than replacing it?
Reputable specialists welcome these questions. They’ll tell you what a treatment can reasonably achieve, and what it can’t. That honesty is often the clearest sign you’re in the right place.
Why the Second Opinion Matters More Than Any Single Therapy
The Grays’ story ends, for now, unresolved. Lawrence wrote that they’re “still trying to find someone who actually knows what options there are other than chemotherapy and radiotherapy.”
That search is the real point. For advanced pancreatic cancer, a pancreatic cancer second opinion at a specialised centre can reveal options that simply aren’t discussed in a general oncology setting. It can also do the opposite. It can confirm that the current plan is the best one, which is worth knowing too.
A pancreatic cancer second opinion in Germany typically means an expert team reviewing:
| What gets reviewed | Why it matters |
| Original imaging (CT, MRI, PET-CT) | Re-reading scans can change staging, especially for small liver lesions |
| Pathology and biopsy material | Confirms tumour type and allows further testing |
| Molecular and genetic profile | Some patients have alterations (BRCA mutations, for example) that open up targeted options |
| Response to previous chemotherapy | Good responders may qualify for treatments poor responders don’t |
| Number and location of metastases | Limited liver disease is assessed differently from widespread disease |
| General condition and organ function | Determines what’s realistically tolerable |
The molecular profile deserves its own mention. Testing a tumour for specific mutations is what turns generic treatment into personalised pancreatic cancer treatment. It’s still underused in many places, and it’s one of the first things a specialist centre will ask about.
For most patients with metastatic disease, the outcome will still be systemic therapy. But “most” isn’t “all.” Some will be candidates for trials, targeted drugs, locoregional liver treatments or, very occasionally, surgery. Nobody can say in advance which group a particular patient belongs to. That’s exactly why the review is worth doing quickly.
Where Booking Health Fits In
Lawrence’s summary of the service is short: “It is not cheap but the service is good.”
What Booking Health does is coordinate. It doesn’t treat patients. Its role is to take the logistics off a family’s hands so they can concentrate on decisions and on each other. For pancreatic cancer treatment in Germany, that usually looks like this:
- Medical records review. The patient’s documents are collected, translated and sent to suitable German specialists.
- Clinic selection. The case is matched to hospitals with relevant expertise, whether that’s a university pancreatic centre for a second opinion or a clinic offering a specific therapy.
- Treatment plan and cost estimate. The family receives a proposed programme and a clear quote before committing.
- Travel and arrival. Appointments are scheduled, and transfers from the airport and to each clinic visit are arranged.
- On-site support. A coordinator and interpreter, Claudia in the Grays’ case, accompanies the patient through consultations and treatment.
- Follow-up. Results and recommendations are passed back so treatment can continue at home.
None of this changes what medicine can do. It changes how fast a family can get to the people who know what medicine can do. With pancreatic cancer, speed isn’t a luxury.
What This Story Means for Other Families
The Grays’ experience doesn’t fit neatly into a success story. Helen’s treatment was well organised and supportive, though harder on her body than they’d expected. Lawrence says so plainly, and he still recommends the route to other families, with conditions attached.
Key takeaways:
- Act early. With metastatic pancreatic cancer, delays close doors. If you’re waiting months for answers, ask whether another centre can see you sooner.
- Prioritise the second opinion. A review by a high-volume pancreatic centre may matter more than any single experimental therapy.
- Treat immunotherapy as what it is. Dendritic cell therapy for pancreatic cancer shouldn’t replace evidence-based care—and nobody should promise you it will work.
- Ask about side effects in detail, including the practical ones, like how tired you’re likely to feel afterwards.
Helen and Lawrence are still searching. They went to Germany hoping to slow things down long enough to get proper expert advice, and they came home with a clearer sense of what they were looking for. They also took home snow, a comedy club, and a translator named Claudia who let them talk too much.
For families exploring advanced pancreatic cancer treatment abroad, Booking Health offers medical records review, specialist second opinions and full treatment coordination at certified German hospitals.
Press Inquiries
Lena Hanten
marketing [at] bookinghealth.com
https://bookinghealth.com/
Media gallery
